BAY-7728
BAY-7728 is an orally active and selective dual inhibitor of KAT6A (IC50: 45 nM)/KAT6B (IC50: 95 nM). BAY-7728 can effectively inhibit tumor growth and regulate the acetylation level of histone H3K23. BAY-7728 can be used for tumor research.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 2767642-46-4
- 화학식: C20H19FN2O5S
- 분자량:418.44
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
BAY-7728 exhibits IC50 values of 55 nM and 164 nM against MVLN and ZR75-1 cells, respectively.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:NMRI nude mice bearing established LCLC-97TM1 human lung cancer xenografts
-
Dosage:2.5-100 mg/kg
-
Administration:Oral, once daily, for 22 consecutive days
-
Result:Demonstrated dose-dependent inhibition of tumor growth and reduction of intratumoral histone H3K23 acetylation (H3K23ac) levels in the LCLC-97TM1 xenograft model.
Was well tolerated at all tested doses, with no significant dose-limiting toxicity observed, and increased systemic exposure (AUC) correlated with enhanced antitumor efficacy.
Chemical Information
-
CAS No. 2767642-46-4
-
분자량 418.44
-
화학식 C20H19FN2O5S
-
SMILES
FC1=C2C(OC(C(NS(=O)(C3=CC=CC=C3OCC)=O)=O)=C2)=CC(N4CCC4)=C1
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)